METHYLIFE-PLUS INJ
MRP: 950
Packaging: 10 x 1ml
Pack Type: injection
Composition:
Methylcobalamin Injection 2500mcg/1ml
Indication:
indicated for the treatment of vitamin B12 deficiency, including conditions such as pernicious anemia and megaloblastic anemia. It is also used in the management of neuropathic pain and diabetic neuropathy, providing support for neurological disorders involving nerve degeneration. Additionally, this injection aids in nerve regeneration after injuries and serves as a dietary supplement for individuals with absorption issues or restrictive diets that may lead to low vitamin B12 levels.
Description:
Methylcobalamin Injection 2500mcg/1ml is a high-strength injectable form of Vitamin B12, specifically in its neurologically active methylcobalamin form. It is used to treat Vitamin B12 deficiency, megaloblastic anemia, and various neurological disorders, especially peripheral neuropathy. Administered intramuscularly (IM) or subcutaneously (SC), it helps restore normal B12 levels, support nerve regeneration, and improve red blood cell production. It is particularly beneficial for patients who cannot absorb B12 through the gastrointestinal tract or need rapid correction of B12 deficiency.
Tags:
- Rapid correction of Vitamin B12 deficiency
- Promotes nerve regeneration and function
- Reduces symptoms of neuropathy (numbness, tingling)
- Improves cognitive and neurological health
- Enhances red blood cell formation
- Boosts energy and reduces fatigue
Usage Information
Dosage
Adult Dose: 2500 mcg (1 ml) via IM or SC injection Treatment Schedule: Loading: Daily or alternate-day for 1–2 weeks Maintenance: Weekly or monthly, based on levels and clinical response Administer under medical supervision only
Side Effects
Common: Injection site pain or swelling Headache Mild diarrhea Nausea Rare but Serious: Allergic reaction (rash, itching, dizziness) Hypokalemia (with prolonged high-dose use) Acneiform eruptions
Contraindications
Hypersensitivity to methylcobalamin, cobalt, or formulation excipients Patients with Leber’s disease (risk of optic nerve atrophy) Severe renal impairment (use with caution) Neonates and premature infants (safety not established)